Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Enzo Biochem (ENZ)

Enzo Biochem (ENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 37,318
  • Shares Outstanding, K 52,244
  • Annual Sales, $ 31,910 K
  • Annual Income, $ -26,080 K
  • EBIT $ -11 M
  • EBITDA $ -9 M
  • 60-Month Beta 0.75
  • Price/Sales 1.15
  • Price/Cash Flow N/A
  • Price/Book 0.77
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.08
  • Most Recent Earnings $-0.05 on 12/16/24
  • Next Earnings Date 12/20/24
  • Annual Dividend & Yield 0.10 (14.00%)
  • Most Recent Dividend 0.100 on 11/15/24
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 334.30% ( -18.24%)
  • Historical Volatility 112.06%
  • IV Percentile 72%
  • IV Rank 41.40%
  • IV High 763.44% on 12/18/24
  • IV Low 31.13% on 07/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 37
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 948
  • Open Int (30-Day) 738

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6823 +7.72%
on 12/17/24
1.1287 -34.88%
on 12/03/24
-0.3350 (-31.31%)
since 12/02/24
3-Month
0.6823 +7.72%
on 12/17/24
1.1900 -38.24%
on 10/30/24
-0.4050 (-35.53%)
since 10/02/24
52-Week
0.6823 +7.72%
on 12/17/24
1.5000 -51.00%
on 01/03/24
-0.7650 (-51.00%)
since 01/02/24

Most Recent Stories

More News
ENZ Stock Falls Post Q1 Earnings Amid Revenue and Demand Challenges

Shares of Enzo Biochem, Inc. ENZ have tumbled 30.9% since the release of its earnings report for the quarter ended Oct. 31, 2024. This compares unfavorably with the S&P 500 Index's 2.9% decline over the...

ENZ : 0.7350 (+2.90%)
Enzo Biochem, Inc. Reports Fiscal Q1 2024 Financial Results and Declares Special Cash Dividend

Enzo Biochem reported a revenue decline of 20% in Q1 2024, alongside strategic leadership changes and a special cash dividend.Quiver AI SummaryEnzo Biochem, Inc. announced its financial results for the...

ENZ : 0.7350 (+2.90%)
Enzo Biochem: Fiscal Q1 Earnings Snapshot

Enzo Biochem: Fiscal Q1 Earnings Snapshot

ENZ : 0.7350 (+2.90%)
Enzo Biochem: Fiscal Q3 Earnings Snapshot

Enzo Biochem: Fiscal Q3 Earnings Snapshot

ENZ : 0.7350 (+2.90%)
Enzo Biochem: Fiscal Q2 Earnings Snapshot

Enzo Biochem: Fiscal Q2 Earnings Snapshot

ENZ : 0.7350 (+2.90%)
Enzo Biochem: Fiscal Q1 Earnings Snapshot

Enzo Biochem: Fiscal Q1 Earnings Snapshot

ENZ : 0.7350 (+2.90%)
Enzo Biochem: Fiscal Q3 Earnings Snapshot

Enzo Biochem: Fiscal Q3 Earnings Snapshot

ENZ : 0.7350 (+2.90%)
SHAREHOLDER ALERT: Weiss Law Investigates Enzo Biochem, Inc.

/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Enzo Biochem, Inc....

ENZ : 0.7350 (+2.90%)
LH : 228.61 (-0.31%)
Enzo Biochem: Fiscal Q2 Earnings Snapshot

Enzo Biochem: Fiscal Q2 Earnings Snapshot

ENZ : 0.7350 (+2.90%)
Stocks Slide Before the Open as First Republic Shares Fall Despite Rescue Deal

June S&P 500 futures (ESM23) are trending down -0.68% this morning after three major U.S. benchmark indices rallied on Thursday as 11 of the nation’s biggest banks injected $30 billion in deposits into...

ESM23 : 4,453.35s (+0.61%)
FRC : 3.51 (-43.30%)
ENZ : 0.7350 (+2.90%)
FDX : 275.68 (-2.01%)
UPS : 124.58 (-1.21%)
NVDA : 135.94 (+1.23%)
X : 32.79 (-3.53%)
SRPT : 125.50 (+3.22%)
WBD : 10.56 (-0.09%)

Business Summary

Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo...

See More

Key Turning Points

3rd Resistance Point 0.7804
2nd Resistance Point 0.7594
1st Resistance Point 0.7369
Last Price 0.7350
1st Support Level 0.6934
2nd Support Level 0.6724
3rd Support Level 0.6499

See More

52-Week High 1.5000
Fibonacci 61.8% 1.1876
Fibonacci 50% 1.0912
Fibonacci 38.2% 0.9947
Last Price 0.7350
52-Week Low 0.6823

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar